Follow Us

Brookside Agra Combines Binder, Mold Inhibitor in Flo-Bond Plus

Brookside Agra has developed a binder and mold inhibitor in one called Flo-Bond Plus for sequestering potentially harmful mycotoxins produced by molds and fungi commonly found in animal feeds and grains.

Mycotoxins are harmful chemicals produced by molds and fungi that pose a significant threat to a variety of animals including cattle, poultry, swine, aquaculture, horses, companion animals and more. Mycotoxins can cause reduced growth rates, cancer, liver and kidney damage, infertility and other problems that can negatively impact profitability.

“Heating, washing or chemical treatments cannot destroy mycotoxins. The only way to eliminate mycotoxins is to deactivate them with a binder like Flo-Bond Plus,” said Tim Nelson, Brookside Agra Vice President – Animal Health & Nutrition Sales. “No matter how large or small your operation, Flo-Bond Plus can supply the defense you need.”

When Flo-Bond Plus is blended with feeds, it binds to (and sequesters) any mycotoxins present, such as various Alfatoxins, Deoxynvalenol (Vomitoxin), Ochratoxin, Zearalenone, T-2 toxin and Fumonisin, as well as inhibits the mold that produces mycotoxins.

When it comes to ensuring real world farm success for its Flo-Bond products, Brookside Agra employs two types of vigorous testing: in-vitro and in-vivo. Using these methods ensures that Flo-Bond products can outperform competitors in a real-world setting, says Nelson.

Brookside Agra used in-vitro lab trials to quickly evaluate competitive products and guide new product development for Flo-Bond products. To mimic the pH levels normally encountered during passage through an animal’s digestive tract, Brookside used a two-step method: Step 1: Absorption phase (at pH 3.0) and Step 2: Desorption phase (at pH 8.0).

Utilizing independent, state-of-the-art, private and university facilities, Brookside Agra subjected Flo-Bond products to in-vivo testing to ensure their effectiveness using live animals with mycotoxin-contaminated feeds.

“The addition of in-vivo trials to our testing regimen separates Flo-Bond products from other competitors whose parent companies often don’t utilize in-vivo research for lack of the required facilities, or because they wish to avoid the added cost of such work. It is our strong belief that in-vivo testing is an absolutely essential requirement for any company selling mycotoxin-binders to the animal feeds and husbandry markets,” said Nelson.

For more information about Flo-Bond Plus, visit www.brookside-agra.com/products/specialty-feed-additives/flo-bond-plus/ or contact Tim Nelson, Vice President – Animal Health & Nutrition Sales, at 402-560-7381 or tim.nelson@brookside-agra.com. Flo-Bond Plus is sold in every continent and over 92 countries.